Literature DB >> 28573905

Regulatory T-cells drive immune dysfunction in CLL.

Deepesh Lad1, Romy Hoeppli2, Qing Huang2, Rosa Garcia2, Lixin Xu2, Cynthia Toze3, Raewyn Broady3, Megan Levings2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28573905     DOI： 10.1080/10428194.2017.1330475

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  6 in total

Review 1.  T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.

Authors:  Elisavet Vlachonikola; Kostas Stamatopoulos; Anastasia Chatzidimitriou
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

2.  Short Research Communication Anti-Spike Antibody Response to COVISHIELD™ (SII-ChAdOx1 nCoV-19) Vaccine in Patients with B-Cell and Plasma Cell Malignancies and Hematopoietic Cell Transplantation Recipients.

Authors:  Madhu Chopra; Arihant Jain; Sanjeev Chhabra; Shaweta Kaundal; Charanpreet Singh; Aditya Jandial; Gaurav Prakash; Alka Khadwal; Chandan Das; Mini P Singh; Reena Das; Pankaj Malhotra; Deepesh P Lad
Journal:  Indian J Hematol Blood Transfus       Date:  2022-03-03       Impact factor: 0.915

3.  Cyclosporine A therapy of chronic lymphoblastic leukemia-related pancytopenia: A case report.

Authors:  Mengying Wang; Ruoyu Meng; Yan Gao; Junxia Huang; Tianlan Li; Chunxia Mao; Shanshan Liu; Yujie Xu; Han Xu; Xianqi Feng
Journal:  Clin Case Rep       Date:  2022-03-10

Review 4.  Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia.

Authors:  Yanyan Liu; Yongping Song; Qingsong Yin
Journal:  Front Immunol       Date:  2022-08-19       Impact factor: 8.786

Review 5.  NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.

Authors:  Paolo Sportoletti; Filomena De Falco; Beatrice Del Papa; Stefano Baldoni; Valerio Guarente; Andrea Marra; Erica Dorillo; Chiara Rompietti; Francesco Maria Adamo; Loredana Ruggeri; Mauro Di Ianni; Emanuela Rosati
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

6.  The impact of immune checkpoint inhibitors in patients with chronic lymphocytic leukemia (CLL): A protocol for a systematic review and meta-analysis of randomized controlled trials.

Authors:  Aviwe Ntsethe; Phiwayinkosi Vusi Dludla; Tawanda Maurice Nyambuya; Siphamandla Raphael Ngcobo; Bongani Brian Nkambule
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.